1. Anti-infection
  2. Bacterial
  3. AcrB-IN-6

AcrB-IN-6 is an effective AcrB inhibitor. AcrB-IN-6 The compound inhibits the function of bacterial multidrug efflux pumps, thereby significantly enhancing the antibacterial activity of various antibiotics. AcrB-IN-6 achieves 32-fold MIC reductions in wild-type E. coli BW25113. AcrB-IN-6 exhibits excellent synergistic antibacterial effects, low cytotoxicity and hemolytic properties. AcrB-IN-6 can be used for researching anti-resistant bacteria.

For research use only. We do not sell to patients.

AcrB-IN-6

AcrB-IN-6 Chemical Structure

CAS No. : 3082621-32-4

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

AcrB-IN-6 is an effective AcrB inhibitor. AcrB-IN-6 The compound inhibits the function of bacterial multidrug efflux pumps, thereby significantly enhancing the antibacterial activity of various antibiotics. AcrB-IN-6 achieves 32-fold MIC reductions in wild-type E. coli BW25113. AcrB-IN-6 exhibits excellent synergistic antibacterial effects, low cytotoxicity and hemolytic properties. AcrB-IN-6 can be used for researching anti-resistant bacteria[1].

In Vitro

AcrB-IN-6 (Compound 11i) (1-512 μg/mL) does not show any anti­bacterial activity against wild-type E. coli<.i> BW25113 or the BW25113 ΔAcrB mutant but demonstrates synergistic activity with six distinct antibiotics included Linezolid (HY-10394), Oxacillin (HY-B0925A), Azithromycin (HY-17506), Erythromycin (HY-B0220), Tetracycline (HY-A0107), Fusidic acid (HY-B1350), Minocycline (HY-17412A), Ampicillin (HY-B0522) and Piperacillin (HY-B1923)[1].
AcrB-IN-6 (50 μM, 0-5 min) inhibits Nile Red activity in wild-type E. coli BW25113[1].
AcrB-IN-6 (128 μg/mL, 0-20 min) does not disrupt the outer membrane permeability and and inner membrane proton motive force of the wild-type E. coli BW25113[1].
AcrB-IN-6 (2-256 μg/mL) does not cause hemolysis of mouse red blood cells and is low cytotoxicity toward mammalian cells[1].
Mcl-1-IN-16 (128 μg/mL, 0-12 h) enhances the post-antibiotic effect of Azithromycin in E. coli BW25113[1].
Mcl-1-IN-16 (16-128 μg/mL, 24 h) combined with Azithromycin and Linezolid exhibits significantly inhibitory effect on biofilm[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

AcrB-IN-6 (Compound 11i) (5-25 mg/kg, i.p., single dose) significantly enhances the in mice antibacterial activity of Tetracycline, showing a dose-dependent synergistic effect[1].
AcrB-IN-6 (5-10 mg/kg, i.p., applied to the wound, for 8 days) enhances the efficacy of Azithromycin in eliminating bacteria during skin infections in mice[1].
AcrB-IN-6 (250-1000 mg/kg, injected in the hemocoel, single dose) demonstrated good safety even at extremely high doses in the Galleria mellonella larvae[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: E. coli BW25113 infection model established in male SPF Kunming (KM) mice (20-22 g)[1]
Dosage: 25 mg/kg (monotherapy); 5 and 15 mg/kg with Tetracycline
Administration: Intraperitoneal injection (i.p.), single dose
Result: Decreased CFU by approximately 0.5 log10 alone.
Proved a more remarkable effect with Tetracycline.
Animal Model: Skin would bacterial infection model established in male SPF Kunming (KM) mice (20-22 g)[1]
Dosage: 5 and 10 mg/kg with Azithromycin
Administration: Applied to the wound, once daily for 8 days
Result: Significantly reduced the bacterial load in the heart, liver, spleen, lungs and kidneys, and completely eliminate the bacteria in some organs.
Showed the same epidermal layer thickness and keratinization condition as normal skin, with no significant pathological changes.
Reduced the level of IL-6.
Molecular Weight

509.48

Formula

C28H33BrN2O2

CAS No.
SMILES

O=C(N1CCCCC1)CN2C3=C(C4=C2C=C(OCC5=CC=C(Br)C=C5)C=C4)CC(C)(C)CC3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

AcrB-IN-6 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
AcrB-IN-6
Cat. No.:
HY-178111
Quantity:
MCE Japan Authorized Agent: